Calif., SF, reviewing other vaccine for monkeypox

The vaccine is made with a live cowpox virus, a close relative to smallpox and monkeypox.
“There is also a risk that people who receive ACAM2000 could accidentally spread the cowpox virus from the vaccine to close contacts who are unvaccinated,” Sanchez stated. “Special training and equipment are also required to administer the vaccine safely and effectively.
People with eczema have a risk of severe disability or death, according to the FDA, due to the live nature of the vaccine. People with a human immunodeficiency virus infection, or eye disease “should be identified and measures should be taken to avoid contact between those individuals and persons with active vaccination lesions,” the FDA states
Links:
https://www.kron4.com/news/calif-sf-reviewing-other-monkeypox-vaccine/
https://www.kron4.com/monkeypox/why-100-million-vaccines-havent-been-used-for-monkeypox/